Clinical Trials on Substance-related Disorder in New Zealand

Total 18190 results

Juul Labs, Inc.

Completed

Comparing the Pharmacokinetics of Nicotine Salt Based ENDS in Healthy Smokers

Tobacco Use | Tobacco Smoking | Nicotine Dependence | Nicotine Dependence, Cigarettes

New Zealand
Juul Labs, Inc.

Completed

Clinical Study Comparing 7 ENDS Products and 1 Combustible Cigarette Using 2 Delivery Methods.

Tobacco Use | Tobacco Smoking | Nicotine Dependence | Nicotine Dependence, Cigarettes

New Zealand
Christchurch Clinical Studies Trust Ltd

Completed

A Study of How Tutin and Hyenanchin, Two Toxins Found in Honey, Are Absorbed and Processed by the Body

Tutin Poisoning

New Zealand
Icahn School of Medicine at Mount Sinai
National Institute on Drug Abuse (NIDA)

Recruiting

Targeting Drug Memories With Methylphenidate

Substance Use Disorder | Cocaine Use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Recruiting

Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults

Opioid-use Disorder

United States
Roswell Park Cancer Institute
National Institutes of Health (NIH)

Completed

Nicotine Vapor Specific Sensory Measurement

Substance-Related Disorder

United States
New York State Psychiatric Institute
Clinilabs, Inc.

Recruiting

Clinical Trials of Multivalent Opioid Vaccine Components

Opioid-use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Assessing Optimal XRB Initiation Points in Jail

Opioid Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Yale University; Clinilabs, Inc.; BioXcel...

Recruiting

Sublingual Dexmedetomidine for Treating Opioid Withdrawal

Opioid Use Disorder | Opioid Withdrawal

United States
Wayne State University
University of New Mexico; Loyola University Chicago; LifeStance Health

Active, not recruiting

Multi-Level Stigma Intervention for Mental Health Services

Substance Use Disorders | Mental Disorder | Social Stigma

United States
Rutgers, The State University of New Jersey
Pfizer

Completed

Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit

Tobacco Use Disorder

United States
GlaxoSmithKline

Withdrawn

Relapse Prevention Study in Newly Abstinent Smokers

Substance Dependence

United States
Yale University
Patient-Centered Outcomes Research Institute

Active, not recruiting

Treatment of Pregnant Women With OUD (SMART)

Opioid-use Disorder

United States
NYU Langone Health

Recruiting

Smartphones for Opiate Addiction Recovery (SOAR)

Opioid-use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Medication-Assisted Treatment for Youth With Substance Use Disorders

Opioid Use Disorder | Opioid Dependence

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA); UConn Health; New York State Office...

Recruiting

Coaching Performance Driven Practice Change in the Context of Value Based Purchasing Under New York Medicaid

Substance Use Disorders | Opioid-use Disorder

United States
Trustees of Dartmouth College
National Institute on Drug Abuse (NIDA)

Recruiting

Implementing a Pharmacist-Integrated Collaborative Model of Medication Treatment for Opioid Use Disorder (PharmICO)

Opioid Use Disorder | Substance Use Disorders

United States
Go Medical Industries Pty Ltd
National Institute on Drug Abuse (NIDA); Columbia University; New York State... and other collaborators

Completed

Pharmacokinetic Study of Vivitrol in Healthy Participants

Opioid-use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Suspended

Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder

Opioid-use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Active, not recruiting

Subthreshold Opioid Use Disorder Prevention (STOP) Trial

Opioid-use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine Responders

Opioid-use Disorder

United States
New York State Psychiatric Institute

Completed

Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder

Opioid-use Disorder

United States
Rutgers, The State University of New Jersey
National Institute on Drug Abuse (NIDA)

Completed

Persistence-Targeted Smoking Cessation (PTSC)

Tobacco Use Disorder

United States
Rutgers University
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Learning-Theory-Based Smoking Cessation Strategies

Nicotine Dependence

United States
New York State Psychiatric Institute
USWM, LLC (dba US WorldMeds)

Completed

Lofexidine for Management of Opioid Withdrawal With XR-NTX Treatment

Opioid-use Disorder

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA); Johns Hopkins University; NYU Langone... and other collaborators

Completed

The Tobacco, Alcohol, Prescription Medication and Other Substances Tool (CTN0059)

Substance Use Disorder

United States
NYU Langone Health
National Institutes of Health (NIH)

Recruiting

ED Observation for Opioid Use Disorder

Opiod Use Disorder

United States
Rowan University
The Cooper Health System

Recruiting

Increasing MAT Engagement With Financial Incentives

Opioid-use Disorder

United States
Rutgers University

Completed

Using Combined EEG and Non-invasive Brain Stimulation to Examine and Improve Reward Functioning in Opioid Use Disorder

Opioid-use Disorder

United States
CBT4CBT, LLC

Completed

CBT4CBT for Office Based Buprenorphine

Opioid-use Disorder

United States
New York State Psychiatric Institute

Terminated

Evaluation of Doxazosin to Alter the Abuse of Oxycodone

Opioid-use Disorder

United States
Yasmin Hurd

Recruiting

Cannabidiol for Opioid Addiction

Opioid Use Disorder

United States
Yasmin Hurd

Completed

Cannabidiol in the Treatment of Opioid Use Disorder

Opioid Use Disorder

United States
New York State Psychiatric Institute

Suspended

A Study of SPG Block for Opioid Withdrawal

Opioid Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Withdrawn

NT-814: Evaluation of Its Ability to Alter the Abuse Liability of Oxycodone in an Exploratory Clinical Study (NT-814)

Opioid Use Disorder

United States
Sangath
Harvard Medical School (HMS and HSDM); London School of Hygiene and Tropical...

Completed

Effectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India (PRIDE)

Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse)

India
Rutgers, The State University of New Jersey
National Institute on Drug Abuse (NIDA)

Completed

Developing a Smoking Cessation Intervention for Methadone Maintained Smokers

Nicotine Dependence | Opiate Dependence

United States
Dartmouth-Hitchcock Medical Center
National Center for Complementary and Integrative Health (NCCIH); Trustees...

Completed

Mindful Moms in Recovery (MMORE)

Opioid-use Disorder

United States
National Institute on Drug Abuse (NIDA)
Research Foundation for Mental Hygiene, Inc.

Completed

Maintenance Treatment for Abstinent Smokers

Tobacco Use Disorder

United States
University of Rochester
National Institute on Drug Abuse (NIDA)

Completed

The Impact of Psychopathic Traits on the Efficacy of a Substance Use Intervention

Substance Use | Psychopathy

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Withdrawn

Assessing Optimal XR-Buprenorphine Initiation Points in Jail

Opioid Use Disorder

United States
Hennepin Healthcare Research Institute
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Recruiting

EXHIT ENTRE Comparative Effectiveness Trial (EXHITENTRE)

Substance Use Disorder | Opioid Use Disorder, Moderate | Opioid Use Disorder, Severe

United States
New York State Psychiatric Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Recruiting

The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking

Alcohol Use Disorder

United States
Albert Einstein College of Medicine
National Institute on Drug Abuse (NIDA); Pfizer; National Institutes of Health...

Active, not recruiting

A Trial of Directly Observed and Long-term Varenicline

Tobacco Use Disorder | Opioid-use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3

Tobacco Use Disorder

United States
New York State Psychiatric Institute

Terminated

Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol

Opioid-use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Effects of E-cigarette Flavors on Youth TCORS 2.0

Nicotine Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Longitudinal Neural Fingerprinting of Opioid-use Trajectories

Opioid Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Recruiting

Telehealth Treatment for Opioid Use Disorders

Opioid Use Disorder

United States
Cerevel Therapeutics, LLC

Recruiting

Positron Emission Tomography (PET) Trial to Evaluate Target Occupancy of CVL-354 at Kappa and Mu Opioid Receptors in Brain Following Oral Dosing

Opioid Use Disorder

United States

Clinical Trials on Substance-related Disorder in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations